Cargando…

Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression

We investigated the association between interleukin-18 (IL-18) polymorphisms and the susceptibility and clinicopathological state of hepatocellular carcinoma (HCC). In total, 901 participants, including 559 healthy controls and 342 patients with HCC, were recruited. The allelic discrimination of -60...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Hon-Kit, Hsieh, Ming-Ju, Yang, Shun-Fa, Wang, Hsiang-Ling, Kuo, Wu-Hsien, Lee, Hsiang-Lin, Yeh, Chao-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946126/ https://www.ncbi.nlm.nih.gov/pubmed/27429592 http://dx.doi.org/10.7150/ijms.15853

Ejemplares similares

Impact of Interleukin-18 Polymorphisms -607A/C and -137G/C on Oral Cancer Occurrence and Clinical Progression
por: Tsai, Hsiu-Ting, et al.
Publicado: (2013)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Shiu, Jr-Shiang, et al.
Publicado: (2018)

Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2017)

Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2017)

Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma
por: Yu, Yung-Luen, et al.
Publicado: (2013)

Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Genetic Polymorphisms of lncRNA LINC00673 as Predictors of Hepatocellular Carcinoma Progression in an Elderly Population
por: Yuan, Lan-Ting, et al.
Publicado: (2022)

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2015)

Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Lin, Chien-Hua, et al.
Publicado: (2020)

Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

Correction: Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

MicroRNA Gene Polymorphisms and Environmental Factors Increase Patient Susceptibility to Hepatocellular Carcinoma
por: Chu, Yin-Hung, et al.
Publicado: (2014)

Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma
por: Yang, Shun-Fa, et al.
Publicado: (2016)

Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-κB and AP-1 Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

Corrigendum to “Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-κB and AP-1 Activity”
por: Yeh, Chao-Bin, et al.
Publicado: (2015)

Elevated Plasma Stromal-Cell-Derived Factor-1 Protein Levels Correlate with Severity in Patients with Community-Acquired Pneumonia
por: Tsai, Ping-Kun, et al.
Publicado: (2014)

Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics
por: Lin, Yang-Hsiang, et al.
Publicado: (2021)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Medical Compliance of Fibrate and the Decreased Risk of Age-Related Macular Degeneration in Dyslipidemia-Related Diseases: A Population-Based Cohort Study
por: Wang, Kai, et al.
Publicado: (2021)

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma
por: Yeh, Chao-Bin, et al.
Publicado: (2014)

Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma
por: Chen, Yao-Li, et al.
Publicado: (2010)

Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation
por: Le, Puo-Hsien, et al.
Publicado: (2019)

Association between TNF-α, Interleukin-18 Polymorphisms and Risk of Hepatocellular Carcinoma in Egyptian patients
por: Sharafelldin, Heba, et al.
Publicado: (2021)

Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan
por: Huang, Wayne Shih-Wei, et al.
Publicado: (2017)

Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development
por: Chen, Chih-Tien, et al.
Publicado: (2018)

Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma
por: Zhu, Shao-Liang, et al.
Publicado: (2016)

Interleukin-3 Polymorphism is Associated with Miscarriage of Fresh in Vitro Fertilization Cycles
por: Wu, Cheng-Hsuan, et al.
Publicado: (2019)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Protodioscin Induces Mitochondrial Apoptosis of Human Hepatocellular Carcinoma Cells Through Eliciting ER Stress-Mediated IP3R Targeting Mfn1/Bak Expression
por: Yu, Chen-Lin, et al.
Publicado: (2022)

The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
por: Yeh, Chao-Bin, et al.
Publicado: (2013)

Correction: The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma
por: Wu, Ming-Sian, et al.
Publicado: (2017)

Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility
por: Lau, Hon-Kit, et al.
Publicado: (2017)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3s7lsibso27489un4jbci6623s